PATENT CLAIM ANALYSIS

Application Number: 15565802
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-05
Patent Classification: ["514", "223800"]

Abstract:
Novel compounds of formula (II) are disclosed. Compounds of formula (II) comprise ornithine derivatives or compounds that may metabolize to ornithine. Also disclosed are methods for the treatment of neurodegenerative diseases such as Alzheimer's Disease using compounds of formula (II).

Claim (Index 10):
The method of  claim 8 , wherein the neurodegenerative disorder is amyotrophic lateral sclerosis (ALS).

Metadata:
- Claim Count in Document: 23.0
- Percentile: 88.0
- Lexical Diversity: 1.5625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10587121', '11346524', '11665520', '10755505', '11665943']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7278747462271138
- 35 USC 102 Novelty (BERT): 0.5293637052624138
- Combined Prediction Score: 0.7080236421306437
- Mean Citation Score: 197.448236
- Max Citation Score: 198.67493
- Similarity Product: 92.36040202320694

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test